Concepedia

Esther A. Reijm

EA

Statistics

Publications

7

Citations

361

H-Index

7

Active since

2010

Affiliations

Erasmus MC(Current)

Erasmus MC Cancer Institute

Sint Franciscus Gasthuis

Ikazia Ziekenhuis

GZA Ziekenhuizen Campus Sint-Augustinus

Esther A. Reijm is an author at Erasmus MC specializing in oncology, molecular oncology, and medicine.

Publications per year

2010–2018

7

Publications

7

Hallmarks of Aromatase Inhibitor Drug Resistance Revealed by Epigenetic Profiling in Breast Cancer

Maurice P.H.M. Jansen, Theo Knijnenburg, Esther A. Reijm et al. · Cancer Research · 2013 · 88 citations · Full text

, , +17

High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer

M. P. H. M. Jansen, Esther A. Reijm, Anieta M. Sieuwerts et al. · Breast Cancer Research and Treatment · 2011 · 70 citations · Full text

, , +17

Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer

Esther A. Reijm, Maurice P.H.M. Jansen, Kirsten Ruigrok-Ritstier et al. · Breast Cancer Research and Treatment · 2010 · 55 citations · Full text

, , +14

High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancer

Esther A. Reijm, A. Mieke Timmermans, Maxime P. Look et al. · Annals of Oncology · 2014 · 52 citations · Full text

, , +16

Gene expression profiles of circulating tumor cells versus primary tumors in metastatic breast cancer

Wendy Onstenk, Anieta M. Sieuwerts, Marleen Weekhout et al. · Cancer Letters · 2015 · 47 citations

, , +17

1–5 of 7